Medical Condition News

RSS

Helmet use may decrease cycling mortality from fatal head injuries

Cyclists who died of a head injury were three times as likely to not be wearing a helmet compared with those who died of other injuries, according to a study in CMAJ.

16 Oct 2012

Comprehensive handbook on vitamin A deficiency disorders

Vitamin A plays a key role among the vitamins essential for healthy growth and development. Vitamin A deficiency disorders (VADD) are therefore an important part of general malnutrition that in the majority of cases leads to failure to thrive and underweight.

16 Oct 2012

New findings on Alzheimer's disease presented at Neuroscience 2012

Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

15 Oct 2012

Einstein College receives $3M grant to establish Glenn Center for the Biology of Human Aging Research

Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.

15 Oct 2012

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.

15 Oct 2012

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

FIGHT HLH Consortium receives EUR 6 million FP7 grant for testing NovImmune's NI-0501

NovImmune SA announced that the European Commission has awarded a 6 million Euros FP7 grant to the "FIGHT HLH" consortium of institutions to support clinical testing of NovImmune's anti-interferon gamma drug candidate, NI-0501.

15 Oct 2012

Smoking cessation programs must be made available for current active-duty war fighters

In a new study published in Frontiers, Dr Timothy Durazzo and colleagues from the San Francisco VA Medical Center and University of California, San Francisco, expand upon their decade of research showing that smoking while kicking the alcohol habit impairs memory, learning and other cognitive skills--ultimately making it more difficult to weather the long storm of sobriety.

15 Oct 2012

Regulatory B cells may provide effective treatment for severe autoimmune diseases

Reproducing a rare type of B cell in the laboratory and infusing it back into the body may provide an effective treatment for severe autoimmune diseases such as multiple sclerosis or rheumatoid arthritis, according to researchers at Duke University Medical Center.

15 Oct 2012

New research on how the brain develops during transition period from childhood to adulthood

Scientists presented new research today on how the brain develops during the dynamic and vulnerable transition period from childhood to adulthood. The findings underscore the uniqueness of adolescence, revealing factors that may influence depression, decision-making, learning, and social relationships.

15 Oct 2012

White blood cell variation can help predict non-blood cancers

Postdoctoral Research Fellow Devin Koestler is a biostatistician in the Geisel School of Medicine at Dartmouth. He develops and applies statistical methods to large volumes of data, seeking new approaches for understanding disease, cancer in particular. Koestler and his colleagues are investigating the potential use of white blood cell variation as a diagnostic, predictive, and research tool in the study of non-blood cancers.

15 Oct 2012

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012

Genkyotex, the leading developer of NOX inhibitors to treat oxygen-radical mediated diseases, announced today that data from single and multiple dose Phase I studies with the NOX 1 and 4 inhibitor, GKT137831, will be presented at Kidney Week 2012.

15 Oct 2012

Abertay lecture to reveal how computer games can help discover new drugs for cancer

How can computer games technology help discover new drugs to treat cancer? This surprising step forward for science will be revealed at a free public lecture at the University of Abertay Dundee this Wednesday at 6pm.

15 Oct 2012

Embryonic neuron transplants could effectively treat brain diseases

The unexpected survival of embryonic neurons transplanted into the brains of newborn mice in a series of experiments at the University of California, San Francisco (UCSF) raises hope for the possibility of using neuronal transplantation to treat diseases like Alzheimer's, epilepsy, Huntington's, Parkinson's and schizophrenia.

15 Oct 2012

Study assesses ethnic disparities among construction workers with injuries

White non-Hispanic construction workers are awarded higher workers' compensation settlements in Illinois than Hispanic or black construction workers with similar injuries and disabilities, according to researchers at the University of Illinois at Chicago School of Public Health.

15 Oct 2012

Scientists reveal interaction between the auditory cortex and amygdala

In a study published in the Journal of Neuroscience and funded by the Wellcome Trust, Newcastle University scientists reveal the interaction between the region of the brain that processes sound, the auditory cortex, and the amygdala, which is active in the processing of negative emotions when we hear unpleasant sounds.

15 Oct 2012

Teagasc researchers look to seaweed for proteins with health benefits

Teagasc researchers are looking to seaweed for proteins with health benefits for use as functional foods. Historically, edible seaweeds were consumed by coastal communities across the world and today seaweed is a habitual diet in many countries, particularly in Asia.

15 Oct 2012

Variable methylation predictive of age, gender, stress, cancer and early-life socioeconomic status

A Simon Fraser University physicist has helped discover that understanding how a chemical mark on our DNA affects gene expression could be as useful to scientists as fingerprints are to police at a crime scene.

15 Oct 2012

Few physicians recommend active surveillance for low-risk prostate cancer

Few physicians recommend active surveillance for low-risk prostate cancer rather than pursuing surgery or radiation, according to a Mayo Clinic study being presented at the North Central Section of the American Urological Association's annual meeting Oct. 10-13 in Chicago.

15 Oct 2012

Pioneering research paves way for new treatments for pulmonary arterial hypertension

Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients suffering from the fatal lung disease pulmonary arterial hypertension (PAH).

15 Oct 2012

Medical Condition News

Helmet use may decrease cycling mortality from fatal head injuries

Comprehensive handbook on vitamin A deficiency disorders

New findings on Alzheimer's disease presented at Neuroscience 2012

Einstein College receives $3M grant to establish Glenn Center for the Biology of Human Aging Research

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

FIGHT HLH Consortium receives EUR 6 million FP7 grant for testing NovImmune's NI-0501

Smoking cessation programs must be made available for current active-duty war fighters

Regulatory B cells may provide effective treatment for severe autoimmune diseases

New research on how the brain develops during transition period from childhood to adulthood

White blood cell variation can help predict non-blood cancers

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012

Abertay lecture to reveal how computer games can help discover new drugs for cancer

Embryonic neuron transplants could effectively treat brain diseases

Study assesses ethnic disparities among construction workers with injuries

Scientists reveal interaction between the auditory cortex and amygdala

Teagasc researchers look to seaweed for proteins with health benefits

Variable methylation predictive of age, gender, stress, cancer and early-life socioeconomic status

Few physicians recommend active surveillance for low-risk prostate cancer

Pioneering research paves way for new treatments for pulmonary arterial hypertension

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News